Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability
- PMID: 34808218
- DOI: 10.1016/j.xphs.2021.11.010
Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability
Abstract
We aimed to understand the impact of the interplay between bile salts and cyclodextrins on the dissolution-permeation of poorly soluble drug compounds with a moderate-strong binding constant to cyclodextrin. Phase diagrams were prepared on the chosen model compound albendazole in phosphate buffer, fasted state simulated intestinal fluid (FaSSIF), and a modified fed state simulated intestinal fluid (FeSSIFmod) with (2-hydroxypropyl)-beta-cyclodextrin (HP-β-CD) concentrations of up to 10 % (m/m). Then we investigated the dissolution/permeation interplay of albendazole dissolved/suspended in the different media through a biomimetic barrier on a 96-well in vitro model. The apparent solubility of albendazole was enhanced by HP-β-CD and FaSSIF/FeSSIFmod separately. However, when albendazole was dissolved in HP-β-CD and biomimetic media together, the solubility was significantly lower than the predicted additive solubility from the solubilizing effects. It is postulated that this is due to the sodium taurocholate from the biomimetic media displacing albendazole from the hydrophobic cavity of HP-β-CD. In the permeation experiments, the highest permeation was observed at cyclodextrin concentrations able to solubilize close to the total dose of albendazole without a major surplus of solubilization capacity. Furthermore, an over-proportional permeation enhancement was observed when both, cyclodextrin and biomimetic media were present. These results indicate that the interplay between bile salts and cyclodextrins can enhance the free (molecularly dissolved) fraction of drug in solution to a greater extent than could be obtained with one of the solubilizing components alone. In conclusion, at carefully selected cyclodextrin-concentrations in combination with biomimetic media, obviously, a transient supersaturation is induced, which is made responsible for the observed major permeation enhancement.
Keywords: Bioavailability; Cyclodextrin(s); Micelle(s); Permeability; Poorly water-soluble drug(s); Solubility; Supersaturation.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media.J Pharm Sci. 2023 May;112(5):1372-1378. doi: 10.1016/j.xphs.2022.12.010. Epub 2022 Dec 17. J Pharm Sci. 2023. PMID: 36539063
-
Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.J Control Release. 2002 Dec 13;85(1-3):45-50. doi: 10.1016/s0168-3659(02)00270-5. J Control Release. 2002. PMID: 12480310
-
Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.Curr Drug Deliv. 2022;19(1):86-92. doi: 10.2174/1567201818666210614104234. Curr Drug Deliv. 2022. PMID: 34126897
-
Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".Eur J Pharm Sci. 2013 Sep 27;50(1):8-16. doi: 10.1016/j.ejps.2013.04.002. Epub 2013 Apr 11. Eur J Pharm Sci. 2013. PMID: 23583787 Review.
-
Implementation of Water-Soluble Cyclodextrin-Based Polymers in Biomedical Applications: How Far Are We?Macromol Biosci. 2022 Aug;22(8):e2200090. doi: 10.1002/mabi.202200090. Epub 2022 May 2. Macromol Biosci. 2022. PMID: 35452159 Review.
Cited by
-
Enabling a novel solvent method on Albendazole solid dispersion to improve the in vivo bioavailability.Eur J Pharm Sci. 2024 May 1;196:106751. doi: 10.1016/j.ejps.2024.106751. Epub 2024 Mar 18. Eur J Pharm Sci. 2024. PMID: 38508502 Free PMC article.
-
Improving the Solubility, Stability, and Bioavailability of Albendazole through Synthetic Salts.Molecules. 2024 Jul 29;29(15):3571. doi: 10.3390/molecules29153571. Molecules. 2024. PMID: 39124976 Free PMC article.
-
The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole.Molecules. 2023 Oct 27;28(21):7295. doi: 10.3390/molecules28217295. Molecules. 2023. PMID: 37959715 Free PMC article.
-
Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins.Pharmaceutics. 2024 Jun 3;16(6):757. doi: 10.3390/pharmaceutics16060757. Pharmaceutics. 2024. PMID: 38931879 Free PMC article.
-
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies.Pharmaceutics. 2023 Feb 9;15(2):592. doi: 10.3390/pharmaceutics15020592. Pharmaceutics. 2023. PMID: 36839914 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous